Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1651 - 1675 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AQ01
  • GalNAcbeta1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260292 1550.855593 C72H130N2O33
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BF01
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260412 1550.855593 C72H130N2O33
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BA01
  • Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261628 1550.855593 C72H130N2O33
Gangliosides LMSP0601AK07
  • GD3(d18:1/24:1(15Z))
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262050 1553.918132 C76H135N3O29
Gangliosides LMSP0601AK05
  • GD3(d18:1/24:0)
  • NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262048 1555.933782 C76H137N3O29
Monoacylglycerophosphoinositolglycans LMGP15040042
  • 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • LPIM6(17:0/0:0)
126457699 1558.628768 C62H111O42P
Pentaacylaminosugars LMSL01050001
  • Bordetella pertussis lipid A
42608337 1558.989734 C78H148N2O24P2
Gangliosides LMSP0601DD04
  • KDNalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262583 1560.912713 C75H136N2O31
Gangliosides LMSP0601DF04
  • Galbeta1-3GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
  • KDN-GM1(d18:1/22:0)
44262599 1560.912713 C75H136N2O31
Gangliosides LMSP0601EB04
  • KDN-lactotetraosylceramide(d18:1/22:0)
  • KDNalpha2-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262759 1560.912713 C75H136N2O31
Gangliosides LMSP0601EC04
  • KDN(2-6)lactotetraosylceramide(d18:1/22:0)
  • KDNalpha2-6Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44262767 1560.912713 C75H136N2O31
Gangliosides LMSP0601GE04
  • KDNalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263167 1560.912713 C75H136N2O31
Gangliosides LMSP0601GG04
  • KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside(d18:1/22:0)
  • KDNalpha2-6Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
44263183 1560.912713 C75H136N2O31
Gangliosides LMSP0601BY02
  • NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262365 1561.871577 C73H131N3O32
Gangliosides LMSP0601CJ02
  • Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262437 1561.871577 C73H131N3O32
Gangliosides LMSP0601FF02
  • NeuGcalpha2-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262981 1561.871577 C73H131N3O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AI02
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type IV H(d18:1/18:0)
44260229 1562.891978 C74H134N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BM02
  • Fucalpha2-3Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260469 1562.891978 C74H134N2O32
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AK02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44260565 1562.891978 C74H134N2O32
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AE02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type I B antigen(d18:1/18:0)
44260645 1562.891978 C74H134N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AE02
  • Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • type II B antigen(d18:1/18:0)
44261005 1562.891978 C74H134N2O32
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CV02
  • Gala 1-3Lex(d18:1/18:0)
  • Galalpha1-3Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261549 1562.891978 C74H134N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AW02
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261613 1562.891978 C74H134N2O32
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BB02
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44261637 1562.891978 C74H134N2O32
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AN03
  • Galalpha1-3Galalpha1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260270 1565.891644 C74H135NO33

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024